ESCI期刊Clinical and Experimental Vaccine Research 2024/2025影响因子:2.199 (CLIN EXP VACCINE RES) (2287-3651). (IMMUNOLOGY)(免

显示全部楼层 · 发表于 2025-3-25 10:18:28

Submitted on: 16 February 2004. Revised on: 02 June 2004. Accepted on: 23 July 2004. ___________________Clinical and Experimental Vaccine Research

显示全部楼层 · 发表于 2025-3-25 14:51:29

Submitted on: 27 August 2015. Revised on: 28 October 2015. Accepted on: 17 November 2015. ___________________Clinical and Experimental Vaccine Research

显示全部楼层 · 发表于 2025-3-25 18:09:29

显示全部楼层 · 发表于 2025-3-25 20:54:41

显示全部楼层 · 发表于 2025-3-26 02:34:31

Submitted on: 27 December 2013. Revised on: 28 February 2014. Accepted on: 23 April 2014. ___________________Clinical and Experimental Vaccine Research

显示全部楼层 · 发表于 2025-3-26 07:20:31

显示全部楼层 · 发表于 2025-3-26 08:54:59

Submitted on: 05 August 2018. Revised on: 16 November 2018. Accepted on: 11 December 2018. ___________________Clinical and Experimental Vaccine Research

显示全部楼层 · 发表于 2025-3-26 13:11:03

显示全部楼层 · 发表于 2025-3-26 16:57:45

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-27 16:19
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved

ESCI期刊Clinical and Experimental Vaccine Research 2024/2025影响因子:2.199 (CLIN EXP VACCINE RES) (2287-3651). (IMMUNOLOGY)(免

浏览过的版块